PDUFA V: Final Recommendations Fund Proposals In Two Of Three Tiers
Industry and FDA agreed to a recommendation package for the PDUFA V commitment letter after dividing agency proposals into three tiers and funding two.
You may also be interested in...
Both ideas also will require more FDA expertise, agency tells industry.
Growth of post-market surveillance system also may require more resources.
CDER Director Woodcock says agency should write down its definition of a surrogate endpoint, but industry and academics will have to help with requirements for biomarker approval.